Symphony Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
+3,092
| New | +$653K | 0.09% | 131 |
|
|
2025
Q1 | – | Sell |
-1,357
| Closed | -$778K | – | 205 |
|
|
2024
Q4 | $778K | Sell |
1,357
-37
| -3% | -$21.2K | 0.12% | 116 |
|
|
2024
Q3 | $856K | Buy |
1,394
+820
| +143% | +$504K | 0.14% | 108 |
|
|
2024
Q2 | $315K | Buy |
574
+128
| +29% | +$70.3K | 0.06% | 164 |
|
|
2024
Q1 | $259K | Buy |
+446
| New | +$259K | 0.06% | 157 |
|
|
2023
Q4 | – | Sell |
-493
| Closed | -$244K | – | 207 |
|
|
2023
Q3 | $244K | Sell |
493
-419
| -46% | -$208K | 0.06% | 141 |
|
|
2023
Q2 | $469K | Buy |
912
+19
| +2% | +$9.78K | 0.12% | 121 |
|
|
2023
Q1 | $504K | Sell |
893
-215
| -19% | -$121K | 0.13% | 132 |
|
|
2022
Q4 | $626K | Sell |
1,108
-48
| -4% | -$27.1K | 0.17% | 113 |
|
|
2022
Q3 | $597K | Sell |
1,156
-34
| -3% | -$17.6K | 0.2% | 112 |
|
|
2022
Q2 | $638K | Sell |
1,190
-82
| -6% | -$44K | 0.19% | 105 |
|
|
2022
Q1 | $767K | Buy |
1,272
+241
| +23% | +$145K | 0.18% | 100 |
|
|
2021
Q4 | $665K | Buy |
1,031
+133
| +15% | +$85.8K | 0.18% | 96 |
|
|
2021
Q3 | $520K | Sell |
898
-26
| -3% | -$15.1K | 0.18% | 94 |
|
|
2021
Q2 | $466K | Buy |
924
+105
| +13% | +$53K | 0.16% | 104 |
|
|
2021
Q1 | $384K | Sell |
819
-371
| -31% | -$174K | 0.1% | 132 |
|
|
2020
Q4 | $562K | Buy |
1,190
+104
| +10% | +$49.1K | 0.2% | 84 |
|
|
2020
Q3 | $480K | Buy |
+1,086
| New | +$480K | 0.2% | 79 |
|